New cancer weapon enters human testing for Tough-to-Treat tumors
Disease control
Recruiting now
This is the first study in people testing a new experimental cancer drug called PHN-012. It aims to find a safe dose and see if it can shrink tumors in patients with advanced colon, lung, or pancreatic cancer who have no other standard treatments left. The study will enroll about…
Phase: PHASE1 • Sponsor: Pheon Therapeutics • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC